» Articles » PMID: 33863995

FXR1 Regulation of Parvalbumin Interneurons in the Prefrontal Cortex is Critical for Schizophrenia-like Behaviors

Abstract

Parvalbumin interneurons (PVIs) are affected in many psychiatric disorders including schizophrenia (SCZ), however the mechanism remains unclear. FXR1, a high confident risk gene for SCZ, is indispensable but its role in the brain is largely unknown. We show that deleting FXR1 from PVIs of medial prefrontal cortex (mPFC) leads to reduced PVI excitability, impaired mPFC gamma oscillation, and SCZ-like behaviors. PVI-specific translational profiling reveals that FXR1 regulates the expression of Cacna1h/Cav3.2 a T-type calcium channel implicated in autism and epilepsy. Inhibition of Cav3.2 in PVIs of mPFC phenocopies whereas elevation of Cav3.2 in PVIs of mPFC rescues behavioral deficits resulted from FXR1 deficiency. Stimulation of PVIs using a gamma oscillation-enhancing light flicker rescues behavioral abnormalities caused by FXR1 deficiency in PVIs. This work unveils the function of a newly identified SCZ risk gene in SCZ-relevant neurons and identifies a therapeutic target and a potential noninvasive treatment for psychiatric disorders.

Citing Articles

Fxr1 Deletion from Cortical Parvalbumin Interneurons Modifies Their Excitatory Synaptic Responses.

Scheuer K, Jansson A, Shen M, Zhao X, Jackson M eNeuro. 2025; 12(1).

PMID: 39753370 PMC: 11735682. DOI: 10.1523/ENEURO.0363-24.2024.


Fast-spiking parvalbumin-positive interneurons: new perspectives of treatment and future challenges in dementia.

Zhang X, Wu M, Cheng L, Cao W, Liu Z, Yang S Mol Psychiatry. 2024; 30(2):693-704.

PMID: 39695324 DOI: 10.1038/s41380-024-02756-6.


An in-depth review of the function of RNA-binding protein FXR1 in neurodevelopment.

Mendez-Albelo N, Sandoval S, Xu Z, Zhao X Cell Tissue Res. 2024; 398(2):63-77.

PMID: 39155323 DOI: 10.1007/s00441-024-03912-8.


The FXR1 network acts as a signaling scaffold for actomyosin remodeling.

Chen X, Fansler M, Janjos U, Ule J, Mayr C Cell. 2024; 187(18):5048-5063.e25.

PMID: 39106863 PMC: 11380585. DOI: 10.1016/j.cell.2024.07.015.


Pathogenesis, diagnosis, and treatment of epilepsy: electromagnetic stimulation-mediated neuromodulation therapy and new technologies.

Jiao D, Xu L, Gu Z, Yan H, Shen D, Gu X Neural Regen Res. 2024; 20(4):917-935.

PMID: 38989927 PMC: 11438347. DOI: 10.4103/NRR.NRR-D-23-01444.


References
1.
Kessler R, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J . The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009; 18(1):23-33. PMC: 3039289. DOI: 10.1017/s1121189x00001421. View

2.
Sullivan P, Kendler K, Neale M . Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003; 60(12):1187-92. DOI: 10.1001/archpsyc.60.12.1187. View

3.
Niwa M, Cash-Padgett T, Kubo K, Saito A, Ishii K, Sumitomo A . DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1. Mol Psychiatry. 2016; 21(11):1488-1489. PMC: 5472474. DOI: 10.1038/mp.2016.154. View

4.
Takata A, Matsumoto N, Kato T . Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci. Nat Commun. 2017; 8:14519. PMC: 5333373. DOI: 10.1038/ncomms14519. View

5.
Liu X, Kelsoe J, Greenwood T . A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region. J Affect Disord. 2015; 189:141-9. PMC: 4640946. DOI: 10.1016/j.jad.2015.09.029. View